Omnicell
OMCL
198 hedge funds and large institutions have $1.21B invested in Omnicell in 2016 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 78 increasing their positions, 71 reducing their positions, and 24 closing their positions.
150% more funds holding in top 10
Funds holding in top 10: 2 → 5 (+3)
29% more capital invested
Capital invested by funds: $938M → $1.21B (+$268M)
10% more repeat investments, than reductions
Existing positions increased: 78 | Existing positions reduced: 71
0% more call options, than puts
Call options by funds: $1K | Put options by funds: $1K
2% less funds holding
Funds holding: 203 → 198 (-5)
13% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 24
Top Buyers
Top Sellers
OMCL Hedge Fund Activity: Q2 2016 in Review
198 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Omnicell (OMCL) for Q2 2016, worth a combined $1.21B — up 29% from $938M a quarter earlier.
Sellers outnumbered buyers: 24 funds closed out of OMCL and 21 opened new positions — a net loss of 3 holders — while 71 trimmed existing stakes and 78 added.
The largest buyer was Cramer Rosenthal McGlynn, opening a new position worth an estimated $17.5M. The largest seller was Conestoga Capital Advisors, cutting an estimated $8.39M.
- 198 institutional investors held Omnicell (OMCL) as of Q2 2016, down from 203 in Q1 2016.
- Funds reported $1.21B of Omnicell stock for Q2 2016, up 29% quarter-over-quarter.
- 21 funds opened new Omnicell positions in Q2 2016 and 24 closed out, a net change of -3 holders.
- The largest Omnicell buyer in Q2 2016 was Cramer Rosenthal McGlynn, an estimated $17.5M added.
- The largest Omnicell seller in Q2 2016 was Conestoga Capital Advisors, an estimated $8.39M sold.
Based on aggregated 13F filings for Q2 2016.